Also known as Reduced Platelet Count
The terms thrombocytopenia and thrombopenia refer to a relative decrease of platelets in blood.
Source: WikipediaWithin all the people who go to their doctor with thrombocytopenia, 26% report having sharp chest pain, 21% report having fatigue, and 13% report having blood in urine. The symptoms that are highly suggestive of thrombocytopenia are bleeding gums, although you may still have thrombocytopenia without those symptoms.
Patients with thrombocytopenia often receive hematologic tests, complete blood count, glucose measurement, electrolytes panel, kidney function tests, complete physical skin exam performed (ml), hemoglobin a1c measurement and x-ray computed tomography .
The most commonly prescribed drugs for patients with thrombocytopenia include hydroxyurea, intramuscular immunoglobulin (baygam), rituximab, zoledronic acid (reclast), epoetin alfa (procrit), anagrelide, filgrastim (neupogen), decitabine, carboplatin, cimetidine, romiplostim (nplate), capecitabine (xeloda) and calcium acetate .
Hydroxyurea | $27 (28 days) | |
Intramuscular Immunoglobulin (Baygam) | ||
Rituximab | $5743 (21 days) | |
Zoledronic Acid (Reclast) | $835 (28 days) | |
Epoetin Alfa (Procrit) | $804 (21 days) | |
Anagrelide | $69 (28 days) | |
Filgrastim (Neupogen) | $1938 (14 days) | |
Decitabine | ||
Carboplatin | $182 (21 days) | |
Cimetidine | $8 (28 days) | |
Romiplostim (Nplate) | ||
Capecitabine (Xeloda) | ||
Calcium Acetate | $103 (28 days) |
Groups of people at highest risk for thrombocytopenia include age 75+ years age 60-74 years.
< 1 years | 0.5x | |
1-4 years | 0.5x | |
5-14 years | 0.8x | |
15-29 years | 0.6x | |
30-44 years | 0.5x | |
45-59 years | 1.1x | |
60-74 years | 1.6x | |
75+ years | 2.2x |
Male | 1.0x | |
Female | 1.0x |
Black | 0.7x | |
Hispanic | 0.9x | |
White | 1.1x | |
Other | 1.3x |